Lytix Biopharma AS (LYTIX)
Market Closed
15 Oct, 02:20 PM
XOSL 
XFRA Primary XOSL kr
7. 80
-0.1
-1.2658%
kr
222.78M Market Cap
- P/E Ratio
- Div Yield
15,370 Volume
-2.26 Eps
kr 7.9
Previous Close Want to track LYTIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lytix Biopharma AS (LYTIX) Statistics
Valuation metrics
Market Cap 222.78M
Enterprise value 603.34M
Trailing P/E (ttm) -6.31
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) -
Price/Book (mrq) 7.28
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 13.21K
Average volume (90 days) 31.9K
Price summary
52-Week low 6.68
52-Week high 11.9
Beta -
50-Day moving average 8.28
200-Day moving average 9.27
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.94%
Return on equity -1.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 7.6%
Book value per share (mrq) 1.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
